COPD III/IV
Clinical trial pipeline · Data from ClinicalTrials.gov
See which COPD III/IV trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which COPD III/IV trials you may qualify forRemimazolam is a new, ultra-short-acting benzodiazepine approved in Romania for procedural sedation. It shows significant clinical benefits compared to other se…
Persistent dyspnea is a debilitating symptom, that is common and difficult to treat. This symptom is found in many different diseases including chronic obstruct…
ADLIFE is a EU-funded project developing innovative digital health solutions to support healthcare planning and care delivery for patients with advanced chronic…